Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 167

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies

Blood (2024) 144 (23): 2375–2388.

https://doi.org/10.1182/blood.2023023616

Published: 2024

Includes: Supplemental data

Journal Articles

Fatty Acid Metabolism Shapes Immune Function and PI3K Inhibitor Sensitivity in Chronic Lymphocytic Leukemia

Yang Zhang, Jun Ma, Hua Wang, Pan Gao, Xin Wang, Ya Zhang

Blood (2024) 144 (Supplement 1): 6763.

https://doi.org/10.1182/blood-2024-208098

Published: 2024

Journal Articles

Study of PC-002 (Sepantronium Bromide), a First-in-Class Inhibitor of Deubiquitinases (DUBs) Targeting Myc Degradation in Relapsed/Refractory c-Myc Rearranged High-Grade B Cell Lymphoma (HGBCL): Updated Phase 2 Results

Blood (2024) 144 (Supplement 1): 3120.

https://doi.org/10.1182/blood-2024-206700

Published: 2024

Journal Articles

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in 86 Pediatric Patients with Aplastic Anemia: A Single-Center Experience

Yue Shang, Yuanyuan Ren, Lipeng Liu, Xin Wang, Chaoqian Jiang, Xia Chen, Yang Wan, Aoli Zhang, Xiaoyan Zhang, Fang Liu, Li Zhang, Yumei Chen, Yao Zou, Xiaojuan Chen, Wenyu Yang, Xiaofan Zhu, Ye Guo

Blood (2024) 144 (Supplement 1): 2174.

https://doi.org/10.1182/blood-2024-199389

Published: 2024

Journal Articles

Genetic Insusceptibility Mediated Inflammation Contributes to Bortezomib-Induced Peripheral Neuropathy

Jialin Zhou, Hanheng Mai, Yunqing Liu, Na Wang, Xiao Lv, Xin Wang, Lili Feng

Blood (2024) 144 (Supplement 1): 1961.

https://doi.org/10.1182/blood-2024-201966

Published: 2024

Journal Articles

Leveraging Population-Scale Multiomic Datasets to Elucidate the Risk of Thrombosis Associated with Protein S ( PROS1 ) Deficiency

Sharjeel A Chaudhry, Amelia K Haj, Justine Ryu, Sean J. Jurgens, Alfonso Rodriguez Espada, Xin Wang, Seung Hoan Choi, Simone Sanna-Cherchi, Kenneth A Bauer, Patrick Ellinor, Pavan K Bendapudi

Blood (2024) 144 (Supplement 1): 17.

https://doi.org/10.1182/blood-2024-205805

Published: 2024

Journal Articles

Using Large-Scale Multiomic Datasets to Assess the Population Frequency of ADAMTS13 Loss-of-Function Variants in the United States and United Kingdom

Amelia K Haj, Sean J. Jurgens, Xin Wang, Justine Ryu, Seung Hoan Choi, Patrick Ellinor, Pavan K Bendapudi

Blood (2024) 144 (Supplement 1): 143.

https://doi.org/10.1182/blood-2024-209189

Published: 2024

Journal Articles

Use of Large-Scale Genomic Datasets to Identify Additional Modifiers of Thrombosis Risk Among 26,436 Carriers of the Factor V Leiden and Prothrombin G20210A Mutations

Justine Ryu, Sean J. Jurgens, Satoshi Koyama, Leo Wijdeveld, Joel Rämö, Amelia K Haj, Xin Wang, Marisa Brake, Alfred I Lee, Kenneth A Bauer, Patrick Ellinor, Pavan K Bendapudi

Blood (2024) 144 (Supplement 1): 18.

https://doi.org/10.1182/blood-2024-207841

Published: 2024

Journal Articles

The Use of Antifungal Prophylaxis Is Associated with Worse Outcomes in Patients with Newly Diagnosed AML Treated with Venetoclax/HMA: A Retrospective Analysis of Patients in the Flatiron Health Database

Alexander J. Ambinder, Mark J. Levis, Xin Wang, Keith W. Pratz, Andrew H Matthews

Blood (2024) 144 (Supplement 1): 2436.

https://doi.org/10.1182/blood-2024-207062

Published: 2024

Journal Articles

Outcomes of Novel Agents Compared to Conventional Treatment in Relapsed and Refractory Diffuse Large B Cell Lymphoma after Second Line Chemoimmunotherapy at the Christie, a Single Centre Retrospective Study

Sonia Raj, Xin Wang, Kim Linton

Blood (2024) 144 (Supplement 1): 6489.

https://doi.org/10.1182/blood-2024-200200

Published: 2024

Journal Articles

Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Nina Kim, Xin Wang, Ilynn Bulatao, Jonathon Vallejo, Yuan Li Shen, Dianne D. Pulte, Marc R. Theoret, R. Angelo De Claro, Kelly J. Norsworthy

Blood (2024) 144 (Supplement 1): 1829.

https://doi.org/10.1182/blood-2024-208514

Published: 2024

Journal Articles

Efficacy and Safety of Primary Letermovir Prophylaxis for Cytomegalovirus Infection in Pediatric Patients Undergoing Allogeneic Transplantation: A Single-Centre, Retrospective, Real-World Analysis

Xin Wang, Chaoqian Jiang, Lipeng Liu, Xia Chen, Yuanyuan Ren, Yang Wan, Aoli Zhang, Xiaoyan Zhang, Yue Shang, Yao Zou, Xiaojuan Chen, Fang Liu, Wenyu Yang, Xiaofan Zhu, Ye Guo

Blood (2024) 144 (Supplement 1): 7274.

https://doi.org/10.1182/blood-2024-197912

Published: 2024

Journal Articles

The Identification of Potential Therapeutic Targets for Lymphoma through Mendelian Randomization

Qianqian Guo, Xin Wang, Juanjuan Shang, Bingyu Liu, Mei Ding, Yang Han, Shunfeng Hu

Blood (2024) 144 (Supplement 1): 6269.

https://doi.org/10.1182/blood-2024-202029

Published: 2024

Journal Articles

Impact of the 15-Item Frailty Scale in IPSS-R/IPSS-M Subgroup of Patients (Pts) with Myelodysplastic Syndromes (MDS)

Xin Wang, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Bing Li, Li Juan Pan, Qingyan Gao, Meng Jiao, Jinying Zhao, Wenjun Xie, Robert Peter Gale, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 6729.

https://doi.org/10.1182/blood-2024-199104

Published: 2024

Journal Articles

Construction and Verification of Prediction Model of Frailty Risk in Elderly Patients with Hematological Neoplasms

Jinying Zhao, Zhang Qianqian, Yating Liu, Bing Li, Wenjun Xie, Erlie Jiang, Xin Wang

Blood (2024) 144 (Supplement 1): 7943.

https://doi.org/10.1182/blood-2024-206404

Published: 2024

Journal Articles

Efficacy and Safety of Dose-Tailored Mitoxantrone Liposomes Combined with Cytarabine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia (Non-M3) Based on Marrow Leukemic Cellularity

Li Hui, FU JIyi, Boyue Zheng, Lianjie HU, Yaqiong LI, Xin WANG, Qing HU, Li Wei, Hai Yi, Ying Yuan, Wang Huan, Yang Haiqing, Xi Yang, Hong Zheng, Yongqian Jia

Blood (2024) 144 (Supplement 1): 6068.

https://doi.org/10.1182/blood-2024-203401

Published: 2024

Journal Articles

Coagulation Factor XII ( F12 ) Haploinsufficiency Is Protective Against Venous Thromboembolism

Amelia K Haj, David Paul, Sharjeel A Chaudhry, Harish Eswaran, Sophia Dhrolia, Sean J. Jurgens, Xin Wang, Lu-Chen Weng, Justine Ryu, Seung Hoan Choi, Satoshi Koyama, Simone Sanna-Cherchi, Wolfgang Bergmeier, Nigel Mackman, Patrick Ellinor, Steven Grover, Pavan K Bendapudi

Blood (2024) 144 (Supplement 1): 133.

https://doi.org/10.1182/blood-2024-209118

Published: 2024

Journal Articles

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

Blood (2024) 144 (6): 615–628.

https://doi.org/10.1182/blood.2023022823

Published: 2024

Includes: Supplemental data

Journal Articles

Patient-Reported Outcome Measures Associated with Overall Survival and Acute Care Use in Patients with Newly Diagnosed Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Acute Lymphoblastic Leukemia

Seiichi Villalona, Xin Wang, Peter Gabriel, Abigail Doucette, Shannon R McCurdy, Alexander Perl, Selina M Luger, Noelle V. Frey, Ximena Jordan Bruno, Elizabeth O Hexner, Daria V Babushok, David L. Porter, Alison W Loren, Keith W Pratz, Catherine Lai

Blood (2023) 142 (Supplement 1): 5183.

https://doi.org/10.1182/blood-2023-178247

Published: 2023

Journal Articles

PRMT1 Promotes Chronic Lymphocytic Leukemia Progression Via Modulating Methylation of MAST1

Zheng Tian, Ya Zhang, Hua Wang, Liyan Lu, Xin Wang

Blood (2023) 142 (Supplement 1): 4628.

https://doi.org/10.1182/blood-2023-183058

Published: 2023

NARROW

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies

Fatty Acid Metabolism Shapes Immune Function and PI3K Inhibitor Sensitivity in Chronic Lymphocytic Leukemia

Study of PC-002 (Sepantronium Bromide), a First-in-Class Inhibitor of Deubiquitinases (DUBs) Targeting Myc Degradation in Relapsed/Refractory c-Myc Rearranged High-Grade B Cell Lymphoma (HGBCL): Updated Phase 2 Results

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in 86 Pediatric Patients with Aplastic Anemia: A Single-Center Experience

Genetic Insusceptibility Mediated Inflammation Contributes to Bortezomib-Induced Peripheral Neuropathy

Leveraging Population-Scale Multiomic Datasets to Elucidate the Risk of Thrombosis Associated with Protein S ( PROS1 ) Deficiency

Using Large-Scale Multiomic Datasets to Assess the Population Frequency of ADAMTS13 Loss-of-Function Variants in the United States and United Kingdom

Use of Large-Scale Genomic Datasets to Identify Additional Modifiers of Thrombosis Risk Among 26,436 Carriers of the Factor V Leiden and Prothrombin G20210A Mutations

The Use of Antifungal Prophylaxis Is Associated with Worse Outcomes in Patients with Newly Diagnosed AML Treated with Venetoclax/HMA: A Retrospective Analysis of Patients in the Flatiron Health Database

Outcomes of Novel Agents Compared to Conventional Treatment in Relapsed and Refractory Diffuse Large B Cell Lymphoma after Second Line Chemoimmunotherapy at the Christie, a Single Centre Retrospective Study

Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Efficacy and Safety of Primary Letermovir Prophylaxis for Cytomegalovirus Infection in Pediatric Patients Undergoing Allogeneic Transplantation: A Single-Centre, Retrospective, Real-World Analysis

The Identification of Potential Therapeutic Targets for Lymphoma through Mendelian Randomization

Impact of the 15-Item Frailty Scale in IPSS-R/IPSS-M Subgroup of Patients (Pts) with Myelodysplastic Syndromes (MDS)

Construction and Verification of Prediction Model of Frailty Risk in Elderly Patients with Hematological Neoplasms

Efficacy and Safety of Dose-Tailored Mitoxantrone Liposomes Combined with Cytarabine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia (Non-M3) Based on Marrow Leukemic Cellularity

Coagulation Factor XII ( F12 ) Haploinsufficiency Is Protective Against Venous Thromboembolism

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

Patient-Reported Outcome Measures Associated with Overall Survival and Acute Care Use in Patients with Newly Diagnosed Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Acute Lymphoblastic Leukemia

PRMT1 Promotes Chronic Lymphocytic Leukemia Progression Via Modulating Methylation of MAST1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only